0000899243-19-027220.txt : 20191113 0000899243-19-027220.hdr.sgml : 20191113 20191113190227 ACCESSION NUMBER: 0000899243-19-027220 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191111 FILED AS OF DATE: 20191113 DATE AS OF CHANGE: 20191113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hayden Michael R CENTRAL INDEX KEY: 0001352908 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 191215768 MAIL ADDRESS: STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION STREET 2: 1203-4464 MARKHAM STREET CITY: VICTORIA STATE: A1 ZIP: V8Z 7X8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 4155004614 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-11 0 0001785173 89bio, Inc. ETNB 0001352908 Hayden Michael R C/O 89BIO, INC. 535 MISSION STREET, 14TH FLOOR SAN FRANCISCO CA 94105 1 0 0 0 Common Stock 2019-11-11 4 P 0 18750 16.00 A 18750 I See footnote Common Stock 2019-11-13 4 C 0 58978 A 77728 I See footnote Series A Preferred Stock 2019-11-13 4 C 0 366667 0.00 D Common Stock 58978 0 I See footnote On November 11, 2019, Genworks 2 Consulting Inc. purchased 18,750 shares of the Issuer's common stock at a price of $16.00 per share in the Issuer's initial public offering. The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-6.217 basis immediately prior the closing of the Issuer's initial public offering on November 13, 2019 and had no expiration date. These shares are held directly by Genworks 2 Consulting Inc., over which the Reporting Person's wife has sole voting and investment power. /s/ Ryan A. Murr, Attorney-in-Fact for Michael R. Hayden 2019-11-13